Suppr超能文献

动脉内与静脉内造影剂对比和慢性肾脏病中的肾损伤:倾向匹配分析。

Intra-Arterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched Analysis.

机构信息

Division of Cardiovascular Medicine, University of Iowa, Iowa City, Iowa, USA.

Department of Nephrology and Hypertension, Glickman Kidney Urological Institute (GUKI), Cleveland Clinic Foundation, Cleveland, Ohio, USA.

出版信息

Nephron. 2019;141(1):31-40. doi: 10.1159/000494047. Epub 2018 Oct 26.

Abstract

BACKGROUND/AIMS: contrast-induced nephropathy (CIN) is well described following an administration of intraarterial contrast, but its occurrence after intravenous (IV) contrast is being questioned. We evaluated the incidence of acute kidney injury (AKI), post-contrast AKI (PC-AKI), CIN, dialysis and mortality in patients with chronic kidney disease (CKD) undergoing non-contrast computed tomography (NCCT) or contrast CT (CCT) or coronary angiography (CoA).

METHODS

We identified individuals who had CoA or CCT or NCCT between 2010 and 2015 in the Cleveland Clinic CKD registry. We used propensity scores to match patients in the 3 groups. We evaluated the proportion of patients that developed AKI and CIN across the groups with chi-square tests. We generated Kaplan-Meier plots comparing mortality and ESRD among patients who developed AKI (in the NCCT group), PC (multifactorial AKI, CIN) AKI and no AKI.

RESULTS

Out of 251 eligible patients, 200 who had CoA were matched to each of the other CT scan groups. The incidence of AKI was 27% in CoA, 24% in CCT and 24% in NCCT (p = 0.72). The incidence of CIN AKI was 16.5% in CoA and 12.5% in CCT (p = 0.26). The Kaplan-Meier survival at 2 years was 74.8 (95% CI 63.8-87.7) for those with CIN and 53.2 (95% CI 39.7-71.4) for those with multifactorial AKI and 56.5 (95% CI 43.4-73.6) for those with AKI-NCCT and 71.4 (95% CI 67.2-76.0) for those without AKI. The Kaplan-Meier ESRD-free estimates at 2 years were 89.9 (95% CI 80.8-100) for those with CIN and 89.4 (95% CI 78.7-100) for those with multifactorial AKI and 77.4 (95% CI 63.6-94.3) for those with AKI-NCCT and 94.4 (95% CI 91.9-97.1) for those without AKI.

CONCLUSION

The administration of both IV and intra-arterial contrast is associated with a risk of AKI. Multifactorial AKI was associated with worse outcomes, while CIN was associated with better outcomes.

摘要

背景/目的:动脉内造影后会出现对比剂诱导的肾病(CIN),但静脉内(IV)造影后其发生情况存在争议。我们评估了慢性肾脏病(CKD)患者在接受非对比计算机断层扫描(NCCT)或对比 CT(CCT)或冠状动脉造影(CoA)时发生急性肾损伤(AKI)、造影后 AKI(PC-AKI)、CIN、透析和死亡率的情况。

方法

我们在克利夫兰诊所 CKD 登记处中确定了 2010 年至 2015 年期间接受 CoA 或 CCT 或 NCCT 的个体。我们使用倾向评分匹配 3 组中的患者。我们使用卡方检验评估各组中出现 AKI 和 CIN 的患者比例。我们生成 Kaplan-Meier 图,比较发生 AKI(在 NCCT 组)、PC(多因素 AKI、CIN)AKI 和无 AKI 的患者之间的死亡率和终末期肾病(ESRD)。

结果

在 251 名符合条件的患者中,200 名接受 CoA 的患者与其他 CT 扫描组中的每一组都进行了匹配。CoA 组 AKI 的发生率为 27%,CCT 组为 24%,NCCT 组为 24%(p=0.72)。CoA 组 CIN-AKI 的发生率为 16.5%,CCT 组为 12.5%(p=0.26)。CIN 组的 2 年生存率为 74.8%(95%CI 63.8-87.7),多因素 AKI 组为 53.2%(95%CI 39.7-71.4),AKI-NCCT 组为 56.5%(95%CI 43.4-73.6),无 AKI 组为 71.4%(95%CI 67.2-76.0)。2 年时无 ESRD 的 Kaplan-Meier 估计值在 CIN 组为 89.9%(95%CI 80.8-100),多因素 AKI 组为 89.4%(95%CI 78.7-100),AKI-NCCT 组为 77.4%(95%CI 63.6-94.3),无 AKI 组为 94.4%(95%CI 91.9-97.1)。

结论

静脉内和动脉内造影剂的应用均与 AKI 风险相关。多因素 AKI 与预后较差相关,而 CIN 与预后较好相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验